226 related articles for article (PubMed ID: 23176303)
1. Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.
Lenhard M; Tereza L; Heublein S; Ditsch N; Himsl I; Mayr D; Friese K; Jeschke U
BMC Cancer; 2012 Nov; 12():553. PubMed ID: 23176303
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients.
Yang XY; Xi MR; Yang KX; Yu H
Gynecol Oncol; 2009 Apr; 113(1):99-104. PubMed ID: 19178934
[TBL] [Abstract][Full Text] [Related]
4. Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma.
Hollis RL; Stanley B; Iida Y; Thomson J; Churchman M; Rye T; Mackean M; Nussey F; Gourley C; Herrington CS
Gynecol Oncol; 2019 Nov; 155(2):318-323. PubMed ID: 31495455
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression and prognostic significance of oestrogen receptor-alpha, oestrogen receptor-beta, and progesterone receptor in stage 1 adult-type granulosa cell tumour of the ovary.
Hutton SM; Webster LR; Nielsen S; Leung Y; Stewart CJ
Pathology; 2012 Dec; 44(7):611-6. PubMed ID: 23149378
[TBL] [Abstract][Full Text] [Related]
8. Steroid hormone receptors and long term survival in invasive ovarian cancer.
Münstedt K; Steen J; Knauf AG; Buch T; von Georgi R; Franke FE
Cancer; 2000 Oct; 89(8):1783-91. PubMed ID: 11042574
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of hormonal receptor status of malignant ovarian tumors.
Tkalia IG; Vorobyova LI; Svintsitsky VS; Nespryadko SV; Goncharuk IV; Lukyanova NY; Chekhun VF
Exp Oncol; 2014 Jun; 36(2):125-33. PubMed ID: 24980769
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the contribution of immunologically-detectable HER2, steroid receptors and of the "triple-negative" tumor status to disease-free and overall survival of women with epithelial ovarian cancer.
de Toledo MC; Sarian LO; Sallum LF; Andrade LL; Vassallo J; de Paiva Silva GR; Pinto GA; Soares FA; Fonseca CD; Derchain SF
Acta Histochem; 2014 Apr; 116(3):440-7. PubMed ID: 24238473
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
[TBL] [Abstract][Full Text] [Related]
13. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ER-α, ER-Β1 and ER-Β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers.
Zhang H; Zhang Z; Xuan L; Zheng S; Guo L; Zhan Q; Qu X; Zhang B; Wang Y; Wang X; Song Y
Clin Transl Oncol; 2012 Mar; 14(3):225-31. PubMed ID: 22374427
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas.
Shabani N; Kuhn C; Kunze S; Schulze S; Mayr D; Dian D; Gingelmaier A; Schindlbeck C; Willgeroth F; Sommer H; Jeschke U; Friese K; Mylonas I
Eur J Cancer; 2007 Nov; 43(16):2434-44. PubMed ID: 17911007
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma.
Park JS; Jung WH; Kim JK; Hwang HK; Cho SI; Yoon DS; Chi HS; Kim BR
J Surg Res; 2009 Mar; 152(1):104-10. PubMed ID: 18394649
[TBL] [Abstract][Full Text] [Related]
17. Expression profile and prognostic role of sex hormone receptors in gastric cancer.
Gan L; He J; Zhang X; Zhang YJ; Yu GZ; Chen Y; Pan J; Wang JJ; Wang X
BMC Cancer; 2012 Dec; 12():566. PubMed ID: 23199240
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of progesterone receptor expression in a population-based analysis.
Caldarella A; Barchielli A
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2505-2509. PubMed ID: 28889189
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.
Sehouli J; Braicu EI; Richter R; Denkert C; Jank P; Jurmeister PS; Kunze CA; Budczies J; Darb-Esfahani S; Schmitt WD; Traut A; Grabowski J; Taube ET; Plett H
Hum Pathol; 2019 Mar; 85():299-308. PubMed ID: 30428389
[TBL] [Abstract][Full Text] [Related]
20. The association between progesterone receptor expression and survival in women with adult granulosa cell tumors.
Puechl AM; Edwards J; Suri A; Nakayama J; Bean S; Gehrig P; Saks E; Duska L; Broadwater G; Ehrisman J; Horowitz N; Secord AA
Gynecol Oncol; 2019 Apr; 153(1):74-79. PubMed ID: 30661765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
